Suppr超能文献

涉及FGF13、miR-504和p53的调控模块调节核糖体生物合成并支持癌细胞存活。

Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

作者信息

Bublik Débora R, Bursać Slađana, Sheffer Michal, Oršolić Ines, Shalit Tali, Tarcic Ohad, Kotler Eran, Mouhadeb Odelia, Hoffman Yonit, Fuchs Gilad, Levin Yishai, Volarević Siniša, Oren Moshe

机构信息

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Department of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, Rijeka 51000, Croatia.

出版信息

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E496-E505. doi: 10.1073/pnas.1614876114. Epub 2016 Dec 19.

Abstract

The microRNA miR-504 targets TP53 mRNA encoding the p53 tumor suppressor. miR-504 resides within the fibroblast growth factor 13 (FGF13) gene, which is overexpressed in various cancers. We report that the FGF13 locus, comprising FGF13 and miR-504, is transcriptionally repressed by p53, defining an additional negative feedback loop in the p53 network. Furthermore, we show that FGF13 1A is a nucleolar protein that represses ribosomal RNA transcription and attenuates protein synthesis. Importantly, in cancer cells expressing high levels of FGF13, the depletion of FGF13 elicits increased proteostasis stress, associated with the accumulation of reactive oxygen species and apoptosis. Notably, stepwise neoplastic transformation is accompanied by a gradual increase in FGF13 expression and increased dependence on FGF13 for survival ("nononcogene addiction"). Moreover, FGF13 overexpression enables cells to cope more effectively with the stress elicited by oncogenic Ras protein. We propose that, in cells in which activated oncogenes drive excessive protein synthesis, FGF13 may favor survival by maintaining translation rates at a level compatible with the protein quality-control capacity of the cell. Thus, FGF13 may serve as an enabler, allowing cancer cells to evade proteostasis stress triggered by oncogene activation.

摘要

微小RNA miR - 504靶向编码p53肿瘤抑制蛋白的TP53 mRNA。miR - 504位于成纤维细胞生长因子13(FGF13)基因内,该基因在多种癌症中过表达。我们报告称,包含FGF13和miR - 504的FGF13基因座受到p53的转录抑制,这在p53网络中定义了一个额外的负反馈回路。此外,我们表明FGF13 1A是一种核仁蛋白,可抑制核糖体RNA转录并减弱蛋白质合成。重要的是,在高表达FGF13的癌细胞中,FGF13的缺失会引发蛋白稳态应激增加,这与活性氧的积累和细胞凋亡相关。值得注意的是,逐步的肿瘤转化伴随着FGF13表达的逐渐增加以及对FGF13生存依赖性的增强(“非癌基因成瘾”)。此外,FGF13的过表达使细胞能够更有效地应对致癌Ras蛋白引发的应激。我们提出,在激活的癌基因驱动过度蛋白质合成的细胞中,FGF13可能通过将翻译速率维持在与细胞蛋白质质量控制能力相适应的水平来促进生存。因此,FGF13可能充当一种促成因素,使癌细胞能够逃避癌基因激活引发的蛋白稳态应激。

相似文献

2
CRKL oncogene is downregulated by p53 through miR-200s.CRKL癌基因通过miR-200家族被p53下调。
Cancer Sci. 2015 Aug;106(8):1033-40. doi: 10.1111/cas.12713. Epub 2015 Jul 14.
8
p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA.p53抑制源自小核仁RNA的致癌性小核仁RNA-28。
PLoS One. 2015 Jun 10;10(6):e0129190. doi: 10.1371/journal.pone.0129190. eCollection 2015.

引用本文的文献

2
Ceramide-induced FGF13 impairs systemic metabolic health.神经酰胺诱导的FGF13损害全身代谢健康。
Cell Metab. 2025 May 6;37(5):1206-1222.e8. doi: 10.1016/j.cmet.2025.03.002. Epub 2025 Mar 31.

本文引用的文献

5
ER proteostasis addiction in cancer biology: Novel concepts.内质网稳态成瘾在癌症生物学中的新概念
Semin Cancer Biol. 2015 Aug;33:40-7. doi: 10.1016/j.semcancer.2015.04.003. Epub 2015 Apr 27.
9
HTSeq--a Python framework to work with high-throughput sequencing data.HTSeq——一个用于处理高通量测序数据的Python框架。
Bioinformatics. 2015 Jan 15;31(2):166-9. doi: 10.1093/bioinformatics/btu638. Epub 2014 Sep 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验